These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 24445831

  • 1. Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis.
    Roine I, Pelkonen T, Bernardino L, Lauhio A, Tervahartiala T, Lappalainen M, Kataja M, Pitkäranta A, Sorsa T, Peltola H.
    Pediatr Infect Dis J; 2014 Jul; 33(7):675-9. PubMed ID: 24445831
    [Abstract] [Full Text] [Related]

  • 2. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
    Sulik A, Wojtkowska M, Oldak E.
    Scand J Immunol; 2008 Sep; 68(3):323-7. PubMed ID: 18565120
    [Abstract] [Full Text] [Related]

  • 3. Changes in MMP-9 and TIMP-1 Concentrations in Cerebrospinal Fluid after 1 Week of Treatment of Childhood Bacterial Meningitis.
    Roine I, Pelkonen T, Lauhio A, Lappalainen M, Cruzeiro ML, Bernardino L, Tervahartiala T, Sorsa T, Peltola H.
    J Clin Microbiol; 2015 Jul; 53(7):2340-2. PubMed ID: 25903567
    [Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis.
    Ichiyama T, Matsushige T, Siba P, Suarkia D, Takasu T, Miki K, Furukawa S.
    J Infect; 2008 May; 56(5):376-80. PubMed ID: 18395263
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holländer GA.
    Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
    [Abstract] [Full Text] [Related]

  • 6. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
    Lindberg RL, Sorsa T, Tervahartiala T, Hoffmann F, Mellanen L, Kappos L, Schaad UB, Leib SL, Leppert D.
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
    [Abstract] [Full Text] [Related]

  • 7. The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.
    Savonius O, Roine I, Alassiri S, Tervahartiala T, Helve O, Fernández J, Peltola H, Sorsa T, Pelkonen T.
    Mediators Inflamm; 2019 Jun; 2019():7436932. PubMed ID: 31780869
    [Abstract] [Full Text] [Related]

  • 8. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
    Tsai HC, Chung LY, Chen ER, Liu YC, Lee SS, Chen YS, Sy CL, Wann SR, Yen CM.
    Am J Trop Med Hyg; 2008 Jan; 78(1):20-7. PubMed ID: 18187780
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E, Castellazzi M, Bellini T, Manfrinato MC, Baldi E, Casetta I, Paolino E, Granieri E, Dallocchio F.
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
    Sunagawa S, Ichiyama T, Honda R, Fukunaga S, Maeba S, Furukawa S.
    Brain Dev; 2009 Sep; 31(8):588-93. PubMed ID: 18849127
    [Abstract] [Full Text] [Related]

  • 13. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J.
    Tuberculosis (Edinb); 2001 Sep; 81(3):203-9. PubMed ID: 11466032
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M, Zampachová E, Elsterová J, Růžek D.
    J Infect; 2014 Feb; 68(2):165-9. PubMed ID: 24091083
    [Abstract] [Full Text] [Related]

  • 16. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
    Dellalibera-Joviliano R, Jacob-Ferreira AL, Joviliano EE, Tanus-Santos JE, Evora PR.
    Vasc Med; 2012 Apr; 17(2):73-8. PubMed ID: 22402936
    [Abstract] [Full Text] [Related]

  • 17. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S, Kim JO, Methe H.
    Am J Cardiol; 2010 Feb 15; 105(4):429-34. PubMed ID: 20152234
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
    Rohini G, Murugeswari P, Prajna NV, Lalitha P, Muthukkaruppan V.
    Cornea; 2007 Feb 15; 26(2):207-11. PubMed ID: 17251814
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.